New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.
about
Role of T cells in type 2 diabetic nephropathyNovel role of parathyroid hormone-related protein in the pathophysiology of the diabetic kidney: evidence from experimental and human diabetic nephropathyAdvanced glycation end products and diabetic complicationsClinical therapeutic strategies for early stage of diabetic kidney disease.Discovery of genes related to diabetic nephropathy in various animal models by current techniques.Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian IndiansFunctional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus.Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions.Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.Inflammation in diabetic kidney diseaseTranscriptomic analysis in diabetic nephropathy of streptozotocin-induced diabetic ratsMindin: a novel marker for podocyte injury in diabetic nephropathy.Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylationOxidative stress mediates nephropathy in type Ia glycogen storage disease.New insight into the molecular drug target of diabetic nephropathy.Inflammatory cytokines in diabetic nephropathy.Antidiabetic and renoprotective effects of Cladophora glomerata Kützing extract in experimental type 2 diabetic rats: a potential nutraceutical product for diabetic nephropathy.Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions.Oral supplementation of diabetic mice with propolis restores the proliferation capacity and chemotaxis of B and T lymphocytes towards CCL21 and CXCL12 by modulating the lipid profile, the pro-inflammatory cytokine levels and oxidative stressAn Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF RatsInfluence of Acute High Glucose on Protein Abundance Changes in Murine Glomerular Mesangial Cells.Ficolin B in Diabetic Kidney Disease in a Mouse Model of Type 1 Diabetes.Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating tInflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathyOxidative stress and cellular stress response in diabetic nephropathy.Progesterone ameliorates diabetic nephropathy in streptozotocin-induced diabetic RatsThioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.Changes of urinary angiotensinogen concentration and its association with urinary proteins in diabetic rats.Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.Influence of protein kinase C (PKC) on the prognosis of diabetic nephropathy patients.Fibrinogen-like protein 2 expression correlates with microthrombosis in rats with type 2 diabetic nephropathy.Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type IaInsights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.Mechanism of oxidative DNA damage in diabetes: tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2'-deoxyguanosine-DNA glycosylaseProtective effects of Danggui Buxue Tang on renal function, renal glomerular mesangium and heparanase expression in rats with streptozotocin-induced diabetes mellitus.A glimpse of various pathogenetic mechanisms of diabetic nephropathy.Oxidative stress in diabetic nephropathy.Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications.
P2860
Q26849691-F97EDE87-B77B-466E-B594-3FF18BF489E1Q26862757-AB1F1F42-505D-47FE-BD70-E32BBCEF75CBQ27687501-866781ED-45D9-4588-82D0-7AD8C4B56577Q30363683-55053A83-7E01-4F19-8079-B90515A50221Q30398783-300387E4-450A-41DB-8ABD-6BE248BC8780Q33281836-051D4584-6C6C-4E6B-A846-73D3DB4E5657Q33479791-A1C59E07-EB85-4213-87C3-A4EA71215608Q33497107-A3A063B1-ED46-402E-A24C-914F4D21E290Q33917811-2D5CB99C-56CE-412C-BFBD-3A5BFCBCD6BEQ34023543-551A9974-DA0A-471B-AD6E-AFCAC5763558Q34137125-1A48F2DB-201C-417D-9CE0-D33E64C514CBQ34151344-E4F11527-7ED6-461B-8972-994F7F308930Q34666690-0220EBB5-FF67-4041-BC68-B5D72C7CAD09Q34807521-3BABA13E-693A-4227-8616-FC32AC312260Q35125585-591FB055-2DA9-46A7-A634-CAC57341C924Q35133177-F291844A-DCCA-46FB-B717-086D50A4B1DDQ35345065-525DAE60-635E-4C1E-871B-97A73C5143A1Q35624799-3D269E15-D429-45D8-A826-1E2CC3F41310Q35775471-99D3DAE2-5B69-46DE-8978-BD5541936484Q35852316-D4342190-D2B9-4113-96C4-C14B2F95D552Q35912899-90438F6D-AB8D-43D0-B737-E95162B4B97FQ35963158-53505703-2C13-4A7F-B10B-7B6C2D21A890Q36086582-D1420252-58BE-4C5C-95C5-F3665EA391DBQ36117573-22D31FA6-331F-4708-A5BA-958554E880D1Q36259336-53E78FF1-9630-4C33-B22A-28FE7BB04B2DQ36292425-217741FE-7FC3-483A-94AE-CF7038DDDAC9Q36314892-DD2B3CEF-298C-45DA-B3DB-529CCEFFA196Q36374983-15F0D75A-27B7-4E58-AB4F-21AF01D00528Q36426843-B941BF39-455F-4601-9AD1-64ACF075717EQ36455977-A9407F29-4B92-4827-897F-C3E0974070CEQ36464709-F9CC8D63-4D0A-4071-8BD8-957F6915E2FBQ36681980-CCD02507-D5AB-4260-94CA-4F753F0F8074Q36717914-8869AE9D-B0FB-472E-AFA7-49F952918669Q36891626-9D77966E-D630-4B9D-B779-F4911E6D66E2Q36906325-DBFC5DA9-BF51-417D-906B-2232492217BAQ36954021-5053EE3F-6002-4547-BEAC-AFC6F6D58AA0Q36979205-766EC72F-5343-4EF2-B961-52E600C23A62Q37003803-1290C131-1F5B-44D8-9C9C-BC680124D7C6Q37050391-E63F9DF7-1798-4B5D-8186-A6594545E12BQ37165694-0609F492-BE7D-41E6-87FD-55DBD035692A
P2860
New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
New insights into the pathophy ...... namics to molecular pathology.
@ast
New insights into the pathophy ...... namics to molecular pathology.
@en
type
label
New insights into the pathophy ...... namics to molecular pathology.
@ast
New insights into the pathophy ...... namics to molecular pathology.
@en
prefLabel
New insights into the pathophy ...... namics to molecular pathology.
@ast
New insights into the pathophy ...... namics to molecular pathology.
@en
P2860
P1476
New insights into the pathophy ...... namics to molecular pathology.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2362.2004.01429.X
P577
2004-12-01T00:00:00Z